Aetna Cuts Prescription Waste And Abuse By 15%
By Cyril Tuohy
InsuranceNewsNet
Aetna programs designed to reduce the use, abuse and waste of prescription drugs slashed usage among its 4.3 million members by 15 percent over a two-year period ending in January 2012.
“We’re encouraged by the evidence that our misuse, waste and abuse programs are controlling access to drugs with high potential for abuse,” said Yrena Friedmann, director, Aetna Pharmacy Management, in a statement. “We’ll continue to do our part to fight prescription drug abuse. We must remain vigilant for the health and safety of our members.”
The results of the study were released at the Pharmacy Benefit Management Institute’s Drug Benefit Conference in Las Vegas last month.
Prescription drug abuse is an epidemic, with about 2.4 million Americans struggling with addiction to prescription painkillers. Opioid addiction is a leading cause of death in the U.S. and adds $72.5 billion in expense to the health care system each year, according to the Centers for Disease Control and Prevention.
Aetna’s prescription drug abuse prevention programs work in four phases.
The first steps are to control access to the prescription drugs at the pharmacy level by limiting how much of the drug is covered by insurance, verifying medical need before coverage of a drug is approved, and advising the pharmacist if the dosage amount appears unsafe, the company said.
The second step reviews each member’s prescription drug history before a new prescription is filled in order to detect usage patterns.
Plan members suspected of abusing a prescription drug are referred to a pain specialist, encouraged to enroll in a pain management program, and referred to company-approved behavioral health specialists and case management experts, the company also said.
For members who don’t respond to support when it’s offered, Aetna could limit access to prescription drug benefits by restricting access to only one health care provider, curtailing refills, and referring plan members suspected of abusing drugs to state and federal agencies, the company said.
Aetna, headquartered in Hartford, Conn., serves more than 37 million people.
Cyril Tuohy is a writer living in Pennsylvania. He has covered the financial services industry for more than 15 years. He has also written about food, restaurants and travel. He can be reached at [email protected].
© Entire contents copyright 2013 by InsuranceNewsNet.com, Inc. All rights reserved. No part of this article may be reprinted without the expressed written consent from InsuranceNewsNet.com.
Cyril Tuohy is a writer based in Pennsylvania. He has covered the financial services industry for more than 15 years. He can be reached at [email protected].



Private Equity Has A Yen For VA Deals
New, Younger Investors Wary Of Advisors
Advisor News
- Advisors get a win as NJ Senate passes independent contractor bill
- Why federal retirement benefits are more complex than advisors realize
- Why timing the market is still a retirement mistake and what to do instead
- Business owners may be overlooking a key part of their financial picture
- How smart investments prepare clients for inflation
More Advisor NewsAnnuity News
- Best’s Special Report: U.S. Life/Annuity Industry Sees Bottom-Line Growth Despite 18% Decline in Total Income in First-Quarter 2026
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- Fortitude Re Completes $500 Million FABN Issuance
- Reframing retirement income for greater certainty
- Jackson Introduces Dow Jones Industrial Average Index Option, Flexible Premiums, Six-Year Rate Guarantee in Latest Registered Index-Linked Annuity Launch
More Annuity NewsHealth/Employee Benefits News
- Wyoming lawmakers mull solutions to rising healthcare costs
- Hospital billing was supposed to be made simpler, but federal law has failed, Sun-Times investigation finds
- AHA FILES AMICUS BRIEF IN CASE CHALLENGING HHS, CMS ON PROVIDER TAXES
- New Geriatrics and Gerontology Findings Reported from University of Pennsylvania (Health insurance, healthcare access, and their roles in the association between blood lead levels and epigenetic aging in United States adults): Aging Research – Geriatrics and Gerontology
- Investigators at Avalere Health Report New Data on Atopic Dermatitis (Tralokinumab as a cost-saving treatment option for adults and adolescents with moderate-to-severe atopic dermatitis enrolled in US health insurance plans: a budget impact …): Skin Diseases and Conditions – Atopic Dermatitis
More Health/Employee Benefits NewsLife Insurance News
- OVER $107 MILLION IN LIFE INSURANCE BENEFITS LOCATED FOR TENNESSEANS IN 2025 THROUGH NAIC'S LIFE INSURANCE POLICY LOCATOR SERVICE
- Maryland Heights man pleads guilty in murder-for-hire death of his mom
- AM Best Affirms Credit Ratings of Everlake Life Group Members
- Industry experts warn NAIC: Fix flawed IUL illustrations now
- InsuranceAUM.com Celebrates a Historic 5th Annual Insurance Investment Executives’ Meeting in Chicago, Honoring Outstanding Industry Leaders and Spotlighting Next Event in Austin
More Life Insurance News